BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

469 related articles for article (PubMed ID: 16552233)

  • 1. Disease mechanism and biomarkers of oral squamous cell carcinoma.
    Brinkman BM; Wong DT
    Curr Opin Oncol; 2006 May; 18(3):228-33. PubMed ID: 16552233
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Molecular markers in oral epithelial dysplasia: review.
    Pitiyage G; Tilakaratne WM; Tavassoli M; Warnakulasuriya S
    J Oral Pathol Med; 2009 Nov; 38(10):737-52. PubMed ID: 19903246
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Overexpression of p53 is an early event in the tumorigenesis of oral squamous cell carcinomas.
    Shintani S; Yoshihama Y; Emilio AR; Matsumura T
    Anticancer Res; 1995; 15(2):305-8. PubMed ID: 7762998
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The hamster model of sequential oral oncogenesis.
    Vairaktaris E; Spyridonidou S; Papakosta V; Vylliotis A; Lazaris A; Perrea D; Yapijakis C; Patsouris E
    Oral Oncol; 2008 Apr; 44(4):315-24. PubMed ID: 18061531
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Immunohistochemical study of p53 and angiogenesis in benign and preneoplastic oral lesions and oral squamous cell carcinoma.
    Abbas NF; Labib El-Sharkawy S; Abbas EA; Abdel Monem El-Shaer M
    Oral Surg Oral Med Oral Pathol Oral Radiol Endod; 2007 Mar; 103(3):385-90. PubMed ID: 17321451
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Aberrant expression and localization of decorin in human oral dysplasia and squamous cell carcinoma.
    Banerjee AG; Bhattacharyya I; Lydiatt WM; Vishwanatha JK
    Cancer Res; 2003 Nov; 63(22):7769-76. PubMed ID: 14633702
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Screening for oral premalignancy and cancer: what platform and which biomarkers?
    Lingen MW
    Cancer Prev Res (Phila); 2010 Sep; 3(9):1056-9. PubMed ID: 20798207
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Precancerous lesions of the buccal mucosa].
    Ben Slama L
    Rev Stomatol Chir Maxillofac; 2001 Apr; 102(2):77-108. PubMed ID: 11446145
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A genetic progression model of oral cancer: current evidence and clinical implications.
    Braakhuis BJ; Leemans CR; Brakenhoff RH
    J Oral Pathol Med; 2004 Jul; 33(6):317-22. PubMed ID: 15200478
    [TBL] [Abstract][Full Text] [Related]  

  • 10. MGMT expression in oral precancerous and cancerous lesions: correlation with progression, nodal metastasis and poor prognosis.
    Sawhney M; Rohatgi N; Kaur J; Gupta SD; Deo SV; Shukla NK; Ralhan R
    Oral Oncol; 2007 May; 43(5):515-22. PubMed ID: 16996781
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Methylation of p16 CpG island associated with malignant progression of oral epithelial dysplasia: a prospective cohort study.
    Cao J; Zhou J; Gao Y; Gu L; Meng H; Liu H; Deng D
    Clin Cancer Res; 2009 Aug; 15(16):5178-83. PubMed ID: 19671846
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Molecular aspects of oral cancer.
    Nagler RM
    Anticancer Res; 2002; 22(5):2977-80. PubMed ID: 12530028
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Lack of molecular markers to predict malignant potential of oral precancer.
    Warnakulasuriya S
    J Pathol; 2000 Mar; 190(4):407-9. PubMed ID: 10699986
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Molecular biology of oral cavity squamous cell carcinoma.
    Kupferman ME; Myers JN
    Otolaryngol Clin North Am; 2006 Apr; 39(2):229-47. PubMed ID: 16580909
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Opportunities and chances for tissue chip microarrays in head and neck surgery. A novel technique for the rapid evaluation of potentially novel biomarkers].
    Hofele C; Joos S; Flechtenmacher C; Bosch FX; Lichter P; Mühling J; Freier K
    Mund Kiefer Gesichtschir; 2002 Nov; 6(6):394-401. PubMed ID: 12447651
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Oral squamous cell carcinoma: new insights.
    Jordan RC; Daley T
    J Can Dent Assoc; 1997; 63(7):517-8, 521-5. PubMed ID: 9264211
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prognostic factors in oral squamous cell carcinoma. A review of the literature.
    Tralongo V; Rodolico V; Luciani A; Marra G; Daniele E
    Anticancer Res; 1999; 19(4C):3503-10. PubMed ID: 10629643
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Identification of a gene signature for rapid screening of oral squamous cell carcinoma.
    Ziober AF; Patel KR; Alawi F; Gimotty P; Weber RS; Feldman MM; Chalian AA; Weinstein GS; Hunt J; Ziober BL
    Clin Cancer Res; 2006 Oct; 12(20 Pt 1):5960-71. PubMed ID: 17062667
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Proliferative activity and loss of function of tumour suppressor genes as 'biomarkers' in diagnosis and prognosis of benign and preneoplastic oral lesions and oral squamous cell carcinoma.
    Girod SC; Pfeiffer P; Ries J; Pape HD
    Br J Oral Maxillofac Surg; 1998 Aug; 36(4):252-60. PubMed ID: 9762452
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The prognostic role of clinical, morphological and molecular markers in oral squamous cell tumors.
    Németh Z; Velich N; Bogdan S; Ujpál M; Szabó G; Suba ZS
    Neoplasma; 2005; 52(2):95-102. PubMed ID: 15800706
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 24.